MarginsXMarginsX
Home › Markets › BETRF

BetterLife Pharma Inc. (BETRF)

BETRF is quoted over the counter, not listed on an exchange. BetterLife Pharma Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Close · November 16, 2026
$0.1513
+7.3% on the day
1-year return
+243.9%
Market cap
$23.0M
Nano cap. From the Nov 16, 2026 close × 151.9M shares (20-F cover page, Jun 1, 2026)
P/E and P/S
Net loss over the period · No revenue line filed
On fiscal year to January 31, 2026 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-16.

Profile

FieldValue
TickerBETRF, quoted over the counter
SEC CIK0001464165
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressVancouver, BC
Incorporated inBC

Warning signs

Cash runway
0.2 months
$9K cash at January 31, 2026
Share count, 1 year
+4.4%
2025-05-30 to 2026-06-01
Going-concern doubt
Yes
20-F filed June 1, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These events or conditions indicate that a material uncertainty exists that casts substantial doubts on our ability to continue as a going concern."
20-F 2026-06-01
Cash and burn$9K cash; operating cash flow -$110K a quarter.Report 2026-01-31
Shares outstanding151,896,675 (2026-06-01); 145,494,883 a year earlier.Cover page 2026-06-01
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorMNP LLP, Vancouver, CanadaPCAOB Form AP 2026-06-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-01-31
Not filed-$1.1M-$439K$9KNo debt tagsNeeds four quarters20-F 2026-06-01
Q3 2019
2018-10-31
Not filed-$3.4M-$706K$407K$2.7MNeeds four quarters10-Q 2018-12-18
Q2 2019
2018-07-31
Not filed-$1.4M-$983K$474K$3.5MNeeds four quarters10-Q 2018-09-14
Q1 2019
2018-04-30
Not filed-$1.6M-$1.9M$1.5M$3.5MNeeds four quarters10-Q 2018-06-19
Q4 2018
2018-01-31
Not filed-$327K-$196K$65K$401KNeeds four quarters10-K 2018-05-01
Q3 2018
2017-10-31
Not filed$531KNot filed$250K$402KNeeds four quarters10-Q 2018-12-18
Q3 2018
2017-10-30
Not filed$531K-$96K$250K$402KNeeds four quarters10-Q 2018-12-18
Q2 2018
2017-07-31
Not filed-$6K-$39K$10K$394KNeeds four quarters10-Q 2018-09-14

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-1/A2010-03-16
Latest annual report20-F2026-06-01
Latest quarterly / interim6-K2026-09-30
Latest current report8-K2019-05-21
Latest proxyDEF 14A2019-02-19

Source: SEC EDGAR submissions feed, 244 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier